AGOMAVAL

This brand name is authorized in Germany, Malta.

Active ingredients

The drug AGOMAVAL contains one active pharmaceutical ingredient (API):

1	Agomelatine UNII A17BS39YWR - AGOMELATINE CITRIC ACID
	Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist. Agomelatine resynchronises circadian rhythms in animal models of circadian rhythm disruption. Agomelatine increases noradrenaline and dopamine release specifically in the frontal cortex and has no influence on the extracellular levels of serotonin.
	Read more about Agomelatine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AGOMAVAL Film-coated tablet	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX22	Agomelatine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	14439142, 14439159
MT	Medicines Authority	MA982/03001